are there natural glp-1 agonists Discovery Hidden in Joints Could Revolutionize Arthritis Treatment GLP-1 Natural Alternatives: Supporting Metabolic
Description
GLP-1 receptor agonists may reduce risk for obesity-related cancers among people with diabetes compared with dipeptidyl peptidase-4 inhibitors, according to findings scheduled for presentation at ASCO Annual Meeting

Treatment was associated with fibrosis improvement by at least one stage with no worsening in non-alcoholic fatty liver disease (NAFLD) activity score in 25% of resmetirom recipients versus just under 15% in the placebo group

Organizations like the American Diabetes Association stress individualized care

In addition to stimulating insulin secretion, these drugs can reduce glucagon production and peak postprandial glucose levels

conventional hypoglycemic drugs: arrhythmic burden, hospitalizations for heart failure, and CRTd responders rate

As we summarise in this concise review, preliminary evidence suggests that the cardioprotective benefits of GLP-1 RAs may also extend to HF
